VEGFA and ovarian hyperstimulation syndrome: This prolonged activity leads to sustained luteotrophic effects, including the release of vasoactive agents such as vascular endothelial growth factor (VEGF), thereby increasing the risk of ovarian hyperstimulation syndrome (OHSS) (8).